AVEO Pharmaceuticals, Inc. (AVEO): Price and Financial Metrics

AVEO POWR Grades

• AVEO scores best on the Growth dimension, with a Growth rank ahead of 87.04% of US stocks.
• AVEO's strongest trending metric is Stability; it's been moving down over the last 177 days.
• AVEO's current lowest rank is in the Momentum metric (where it is better than 5.17% of US stocks).

AVEO Stock Summary

• AVEO PHARMACEUTICALS INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 84.44% of US listed stocks.
• Revenue growth over the past 12 months for AVEO PHARMACEUTICALS INC comes in at 269.37%, a number that bests 96.62% of the US stocks we're tracking.
• In terms of volatility of its share price, AVEO is more volatile than 92.64% of stocks we're observing.
• Stocks that are quantitatively similar to AVEO, based on their financial statements, market capitalization, and price volatility, are SRI, AIM, NURO, BJDX, and SONM.
• AVEO's SEC filings can be seen here. And to visit AVEO PHARMACEUTICALS INC's official web site, go to www.aveooncology.com.

AVEO Valuation Summary

• In comparison to the median Healthcare stock, AVEO's EV/EBIT ratio is 304.15% lower, now standing at -19.7.
• Over the past 156 months, AVEO's price/sales ratio has gone down 6.5.

Below are key valuation metrics over time for AVEO.

AVEO Growth Metrics

Its 2 year net income to common stockholders growth rate is now at -9263.5%.
• Its 2 year price growth rate is now at -29.51%.
• The year over year net cashflow from operations growth rate now stands at -5.63%.

Over the past 15 months, AVEO's revenue has gone up $80,357,000.

The table below shows AVEO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	94.319	-22.661	-29.039
2022-06-30	79.043	-30.927	-36.141
2022-03-31	61.295	-47.142	-41.419
2021-12-31	42.295	-57.257	-53.342
2021-09-30	25.535	-57.953	-57.591
2021-06-30	13.962	-55.768	-55.616

AVEO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• AVEO has a Quality Grade of D, ranking ahead of 14.08% of graded US stocks.
• AVEO's asset turnover comes in at 0.147 -- ranking 224th of 682 Pharmaceutical Products stocks.
• LXRX, SEEL, and OTLK are the stocks whose asset turnover ratios are most correlated with AVEO.

The table below shows AVEO's key quality metrics over time.